KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessReceivables - NetReceivables - OtherShares Issued
Ratios

Gilead Sciences (GILD) Receivables - Net (2016 - 2025)

Gilead Sciences' Receivables - Net history spans 17 years, with the latest figure at $4.9 billion for Q4 2025.

  • For Q4 2025, Receivables - Net fell 7.63% year-over-year to $4.9 billion; the TTM value through Dec 2025 reached $4.9 billion, down 7.63%, while the annual FY2025 figure was $4.9 billion, 7.63% down from the prior year.
  • Receivables - Net reached $4.9 billion in Q4 2025 per GILD's latest filing, down from $5.1 billion in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $5.5 billion in Q4 2023 to a low of $3.8 billion in Q1 2022.
  • Average Receivables - Net over 5 years is $4.6 billion, with a median of $4.7 billion recorded in 2021.
  • Peak YoY movement for Receivables - Net: grew 29.9% in 2021, then dropped 18.51% in 2022.
  • A 5-year view of Receivables - Net shows it stood at $4.5 billion in 2021, then increased by 6.32% to $4.8 billion in 2022, then rose by 15.03% to $5.5 billion in 2023, then decreased by 3.2% to $5.3 billion in 2024, then decreased by 7.63% to $4.9 billion in 2025.
  • Per Business Quant, the three most recent readings for GILD's Receivables - Net are $4.9 billion (Q4 2025), $5.1 billion (Q3 2025), and $4.8 billion (Q2 2025).